Abstract:Bays are transition zones connecting freshwater ecosystems and marine ecosystems, and they are strongly influenced by intensive human activities. Pharmaceuticals are of concern in bay aquatic environments because of their potential threat to marine food web. We studied the occurrence, spatial distribution, and ecological risks of 34 pharmaceutical active compounds (PhACs) in Xiangshan Bay, a heavily industrialized and urbanized area in Zhejiang Province, Eastern China. PhACs were ubiquitously detected in the coastal waters of the study area. A total of twenty-nine compounds were detected in at least one sample. Carbamazepine, lincomycin, diltiazem, propranolol, venlafaxine, anhydro erythromycin, and ofloxacin had the highest detection rate (≥ 93%). These compounds were detected with maximum concentrations of 31, 127, 0.52, 1.96, 2.98, 75, and 98 ng/L, respectively. Human pollution activities included marine aquacultural discharge and effluents from the local sewage treatment plants. These activities were the most influential sources in this study area based on principal component analysis. Lincomycin was an indicator of veterinary pollution of coastal aquatic environment, and the concentrations of lincomycin were positively related to the total phosphorus in this area (r = 0.28, p < 0.05). Typical PhACs such as venlafaxine, ofloxacin, norfloxacin, roxithromycin, and clarithromycin were significantly and positively correlated with nitrate and total nitrogen (r > 0.26, p < 0.05) based on Pearson's correlation analysis. Carbamazepine was negatively correlated with salinity (r < - 0.30, p < 0.01). Land use pattern was also correlated with the occurrence and distribution of PhACs in the Xiangshan Bay. Some PhACs, i.e., ofloxacin, ciprofloxacin, carbamazepine, and amitriptyline posed medium to high ecological risks to this coastal environment. The results of this study could be helpful to understand the levels of pharmaceuticals, potential sources, and ecological risks in marine aquacultural environment.

Occurrence, spatial and seasonal variation, and environmental risk of pharmaceutically active compounds in the Pearl River basin, South China

Occurrence and a Screening‐level Risk Assessment of Human Pharmaceuticals in the Pearl River System, South China

Occurrence of Steroid Estrogens, Endocrine-Disrupting Phenols, and Acid Pharmaceutical Residues in Urban Riverine Water of the Pearl River Delta, South China.

Occurrence and Behavior of Non-Steroidal Anti-Inflammatory Drugs and Lipid Regulators in Wastewater and Urban River Water of the Pearl River Delta, South China.

Biogeochemical characteristics and ecological risk assessment of pharmaceutically active compounds (PhACs) in the surface seawaters of Jiaozhou Bay, North China.

Pharmaceutical active compounds in a heavily industrialized and urbanized bay, Eastern China

Occurrence and Behavior of Pharmaceuticals, Steroid Hormones, and Endocrine-Disrupting Personal Care Products in Wastewater and the Recipient River Water of the Pearl River Delta, South China.

Occurrence and Risk Assessment of Acidic Pharmaceuticals in the Yellow River, Hai River and Liao River of North China.

Pharmaceutically Active Compounds (phacs) in Surface Sediments of the Jiaozhou Bay, North China.

Pharmaceuticals and Personal Care Products in Water, Sediments, Aquatic Organisms, and Fish Feeds in the Pearl River Delta: Occurrence, Distribution, Potential Sources, and Health Risk Assessment.

Source Apportionment, Hydrodynamic Influence, and Environmental Stress of Pharmaceuticals in a Microtidal Estuary with Multiple Outlets in South China

Pharmaceutically active compounds in the Xiangjiang River, China: Distribution pattern, source apportionment, and risk assessment.

Contamination of Typical Phthalate Acid Esters in Surface Water and Sediment of the Pearl River, South China: Occurrence, Distribution, and Health Risk Assessment.

Characterization of Pharmaceutically Active Compounds in Beijing, China: Occurrence Pattern, Spatiotemporal Distribution and Its Environmental Implication.

Pollution Characterization of Pharmaceutically Active Compounds (phacs) in the Northwest of Tai Lake Basin, China: Occurrence, Temporal Changes, Riverine Flux and Risk Assessment.

Characteristics of Pharmaceutically Active Compounds in Surface Water in Beijing, China: Occurrence, Spatial Distribution and Biennial Variation from 2013 to 2017.

Occurrence and Environmental Risk of Endocrine-Disrupting Chemicals in Surface Waters of the Pearl River, South China

Determination of phenolic endocrine disrupting chemicals and acidic pharmaceuticals in surface water of the Pearl Rivers in South China by gas chromatography-negative chemical ionization-mass spectrometry.

Occurrence, source estimation and risk assessment of pharmaceuticals in the Chaobai River characterized by adjacent land use

Occurrence and Fate of PPCPs and Correlations with Water Quality Parameters in Urban Riverine Waters of the Pearl River Delta, South China

The Relative Risk and Its Distribution of Endocrine Disrupting Chemicals, Pharmaceuticals and Personal Care Products to Freshwater Organisms in the Bohai Rim, China.